Bifogade filer
PDF
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Eevia Health PLC ("Eevia" or "The Company") has received multiple new sales orders for products totaling KEUR 54 from various European and Asian customers.
For immediate release
Seinäjoki, Finland 11.2.2025
Following the opening day of BIOFACH 2025, a world leading organic trade fair, four customers placed sales orders totaling KEUR 54 (KESEK 619) with Eevia. These included two German customers through our distributor BREKO for Feno-Myrtillus™ 36. One of the German orders were for Fenoprolic™ Full Spectrum, a pine extract with a wide specter of oligomeric proanthocyanidins.
A small order came in for a tart cherry extract with 5% polyphenols (Feno-Ceraus™ 5) from Australia. From Taiwan, Eevia received an order for Feno-Myrtillus 25 of c. KEUR 15.
Eevia has all products in stock, allowing immediate delivery without the need for raw material purchases or production, which benefits cash flow. These are repeat orders, and further orders from these customers are expected.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
As a pioneering company, Eevia is developing high-value food ingredients, blended solutions, and biomaterials that significantly benefit human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.